Dravet Syndrome Disease Modification Beyond Seizure Control

This episode, titled “Dravet Syndrome Disease Modification Beyond Seizure Control,” features panelists discussing the evolving role of disease-modifying therapies across the full spectrum of Dravet syndrome, including adolescents and adults. Building on prior discussions of emerging therapeutic approaches, the expert faculty explore whether interventions targeting the underlying biology of Dravet syndrome may provide meaningful benefits beyond seizure reduction alone.

The panel examines an important clinical question: can disease-modifying therapies improve outcomes in patients whose seizures are already relatively well controlled? Faculty discuss how many individuals with Dravet syndrome continue to experience significant challenges related to cognition, behavior, anxiety, gait impairment, functional independence, and quality of life despite improvements in seizure frequency. The conversation highlights the possibility that future therapies may address broader manifestations of the disease and potentially alter long-term trajectories.

Panelists also consider the implications of treating adult patients with Dravet syndrome. Although earlier intervention is expected to yield the greatest benefit, the faculty emphasize that existing clinical data suggest older patients may still experience meaningful improvements. The discussion explores the potential for disease modification across different age groups and the importance of evaluating outcomes beyond traditional seizure endpoints.

In addition, the panel reviews how disease-modifying therapies may ultimately complement, rather than replace, established antiseizure medications. Faculty discuss the possibility that restoring SCN1A function could enhance responsiveness to existing therapies and improve overall disease management. Throughout the episode, the expert panel emphasizes a future treatment paradigm focused not only on seizure control but also on improving function, independence, and quality of life for patients living with Dravet syndrome.

In the next episode, “Family Burden and Lifelong Care Planning in Dravet Syndrome,” panelists will discuss practical strategies for supporting caregivers and improving long-term care planning across the lifespan. The expert faculty will also explore how multidisciplinary resources, family organizations, and transition planning can help address the evolving needs of patients with Dravet syndrome and their families.